Zachariah DeFilipp
Overview
Explore the profile of Zachariah DeFilipp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
2244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munshi P, Olin R, Wall S, McCurdy S, Al-Juhaishi T, Baker J, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39961473
Geriatric assessment (GA) may identify vulnerabilities and promote risk-stratification in older adults predisposed to toxicities after autologous (auto), allogeneic (allo) hematopoietic cell transplantation (HCT) and chimeric antigen T-cell therapies (CAR...
2.
El-Jawahri A, Reese J, Traeger L, Dizon D, Cutler C, Bober S, et al.
J Natl Compr Canc Netw
. 2025 Feb;
23(2).
PMID: 39938468
Background: Interventions to address sexual health in hematopoietic stem cell transplant (HSCT) survivors are limited. Methods: We conducted a pilot randomized trial of a digital app, SHIFT (Sexual Health and...
3.
Frigault M, Yao E, Berger T, Wehrli M, Gallagher K, Horick N, et al.
Blood Adv
. 2025 Feb;
PMID: 39928957
Chimeric antigen receptor T (CAR-T) cell therapy is limited by cytokine release syndrome (CRS) and neurotoxicity (NT). We sought to use once-daily prophylactic anakinra, an IL-1R antagonist, to prevent CRS/NT...
4.
Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, et al.
Transplant Cell Ther
. 2024 Dec;
31(1):10.e1-10.e9.
PMID: 39667999
Background: The standard treatment for acute graft-vs-host disease (GVHD), a common complication following allogeneic hematopoietic cell transplant, remains prolonged courses of high dose corticosteroids. Previous attempts to decrease corticosteroid exposure...
5.
6.
Somasundaram E, Gill R, Hartford N, Collier K, McAfee S, Dey B, et al.
Transplant Cell Ther
. 2024 Nov;
31(1):45.e1-45.e7.
PMID: 39542361
Hematopoietic cell transplantation (HCT) remains the definitive therapeutic modality for numerous malignant and non-malignant hematologic disorders. Conventional bone marrow remains a viable donor source for HCT. However, microbial contamination of...
7.
DeFilipp Z, Fox L, Holderried T, Mehra V, Michonneau D, Pashley A, et al.
Transplant Cell Ther
. 2024 Nov;
31(2):76.e1-76.e13.
PMID: 39536878
The objective of this meta-analysis (MA) was to evaluate the efficacy and safety of extracorporeal photopheresis (ECP) for the treatment of steroid-refractory chronic graft-versus-host disease (SR-cGvHD). A systematic literature review...
8.
Pidala J, Pidala J, Kim J, Kalos D, Cutler C, Cutler C, et al.
Blood Adv
. 2024 Oct;
9(5):1040-1048.
PMID: 39454280
To examine the activity of ibrutinib in steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after the US Food and Drug Administration approval, we conducted a multicenter retrospective study. Data were standardly collected...
9.
DeFilipp Z, Kim H, Cheng G, Hamilton B, Chhabra S, Hamadani M, et al.
Blood Adv
. 2024 Oct;
9(2):244-253.
PMID: 39365992
Bronchiolitis obliterans syndrome (BOS) occurring after allogeneic hematopoietic cell transplantation (HCT) is a high-risk manifestation of chronic graft-versus-host disease. In this prospective, multicenter phase 2 trial, adult participants with BOS...
10.
Iftikhar R, DeFilipp Z, DeZern A, Pulsipher M, Bejanyan N, Burroughs L, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1155-1170.
PMID: 39307421
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for severe aplastic anemia (SAA). Existing guidance about HCT in SAA is primarily derived from expert reviews, registry data and...